Sisram Medical Ltd. (HK:1696)
:1696
Want to see HK:1696 full AI Analyst Report?
1696 Stock Chart & Stats
HK$3.87
-HK$0.01(-0.28%)
At close: 4:00 PM EST
HK$3.87
-HK$0.01(-0.28%)
Day’s Range― - ―
52-Week RangeHK$2.43 - HK$8.07
Previous CloseN/A
Volume75.47K
Average Volume (3M)469.37K
Market Cap
HK$1.18B
Enterprise ValueHK$142.75M
Total Cash (Recent Filing)HK$70.96M
Total Debt (Recent Filing)HK$51.75M
Price to Earnings (P/E)7.9
Beta1.13
Next Earnings
Aug 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.82%
Share Statistics
EPS (TTM)0.04
Shares Outstanding468,343,080
10 Day Avg. Volume515,040
30 Day Avg. Volume469,367
Financial Highlights & Ratios
PEG Ratio-0.55
Price to Book (P/B)0.53
Price to Sales (P/S)0.69
P/FCF Ratio37.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$4.50Price Target Upside16.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.48
Revenue Forecast (FY)HK$3.22B
Bulls Say, Bears Say
Bulls Say
Recurring Revenue ModelSisram’s business model pairs one-time capital sales with recurring consumables, service contracts and distributor-driven placements. That installed-base monetization creates durable annuity-like revenue, smoothing cycles in capital equipment demand and supporting long-term cash visibility.
Conservative Balance SheetThe company’s low debt burden and growing equity provide financial flexibility to fund R&D, service infrastructure and selective M&A without heavy refinancing risk. A conservative balance sheet also cushions cyclical equipment demand and supports long-term strategic investments.
High Gross MarginsSustained ~59% gross margins indicate favorable product economics and pricing power on core devices and consumables. Combined with multi-year revenue expansion, healthy gross margins underpin long-term profitability potential and capacity to reinvest in product development and service capabilities.
Bears Say
Margin CompressionA sharp drop from double-digit to ~5.2% net margin signals sustained margin pressure from higher operating costs, pricing erosion or unfavorable mix. If structural, this reduces retained earnings, limits reinvestment capacity and weakens long-term return on capital.
Weak Cash GenerationThe pronounced fall in operating and free cash flow and poor cash conversion indicate working-capital stress or higher investment needs. Lower cash generation constrains funding for growth initiatives, maintenance capex and services expansion without drawing on reserves or new financing.
Uneven Revenue TrajectoryInconsistent top-line performance—an interim decline followed by modest recovery—suggests exposure to cyclical equipment demand, distributor variability or market share pressure. Persistent uneven growth hampers predictability and makes long-term operational planning and margin recovery harder.
Sisram Medical Ltd. News
1696 FAQ
What was Sisram Medical Ltd.’s price range in the past 12 months?
Sisram Medical Ltd. lowest stock price was HK$2.43 and its highest was HK$8.07 in the past 12 months.
What is Sisram Medical Ltd.’s market cap?
Sisram Medical Ltd.’s market cap is HK$1.18B.
When is Sisram Medical Ltd.’s upcoming earnings report date?
Sisram Medical Ltd.’s upcoming earnings report date is Aug 26, 2026 which is in 73 days.
How were Sisram Medical Ltd.’s earnings last quarter?
Sisram Medical Ltd. released its earnings results on Mar 23, 2026. The company reported HK$0.21 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.21.
Is Sisram Medical Ltd. overvalued?
According to Wall Street analysts Sisram Medical Ltd.’s price is currently Undervalued.
Does Sisram Medical Ltd. pay dividends?
Sisram Medical Ltd. pays a Annually dividend of HK$0.126 which represents an annual dividend yield of 2.82%. See more information on Sisram Medical Ltd. dividends here
What is Sisram Medical Ltd.’s EPS estimate?
Sisram Medical Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sisram Medical Ltd. have?
Sisram Medical Ltd. has 468,343,080 shares outstanding.
What happened to Sisram Medical Ltd.’s price movement after its last earnings report?
Sisram Medical Ltd. reported an EPS of HK$0.21 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -6.316%.
Which hedge fund is a major shareholder of Sisram Medical Ltd.?
Currently, no hedge funds are holding shares in HK:1696
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sisram Medical Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
HK$4.50 (16.28% Upside)
HK$4.50 (16.28% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
26.21%
12-Months-Change
Fundamentals
Return on Equity
4.02%
Trailing 12-Months
Asset Growth
2.43%
Trailing 12-Months
Company Description
Sisram Medical Ltd.
Sisram Medical Ltd, an investment holding company headquartered in Caesarea, Israel, since its establishment in 2013, is engaged in the creation, production, and worldwide distribution of a broad spectrum of medical solutions. The company develops and markets energy-based aesthetic devices, minimally invasive therapeutic systems, non-energy-dependent equipment, and cosmeceuticals, reaching markets across Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. Its comprehensive range of products and treatments addresses numerous conditions, such as hair removal, skin revitalization, acne and scarring, body and facial sculpting, pigment and skin surface refinement, fat transfer procedures, injectable dermal fillers, skin tissue regeneration injectables, personal wellness items, cosmetic dental procedures, transdermal delivery methods, cellulite reduction, stretch mark amelioration, therapy for vascular and pigmented lesions, hydradermabrasion, non-surgical eyelid lifts (blepharoplasty), liposuction, as well as feminine health and sexual well-being applications. Furthermore, the company is involved in the manufacturing, distribution, and sales of general medical apparatus. Sisram Medical's offerings are available under its prominent brand names, which include Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT.
1696 Stock 12 Month Forecast
Average Price Target
HK$4.50
▲(16.28% Upside)
Technical Analysis
Peijia Medical Ltd.
―
Yestar Healthcare Holdings Co Ltd
―
Gaush Meditech Ltd.
―
Venus Medtech (Hangzhou), Inc. Class H
―
Austar Lifesciences Ltd.
―
Options Prices
Currently, No data available
---